This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Guilford Pharmaceuticals gets $27.2mm from investors
18 Dec 2003
Guilford Pharmaceuticals (therapeutics for neurology and hospital markets) sold 4.8mm common shares at $5.67 each (a 15% discount to market), grossing $27.2mm, to Sage Capital, OrbiMed Advisors, Highbridge Capital, Domain Associates, UBS O'Connor LLC, Quogue Capital, and Merlin BioMed. The investors also received 7-year warrants to buy about 961.4k additional common shares at $7.55 each.
Private Investment in Public Equity
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?